TherapeuticsMD Inc (TXMD)

6.00
0.27 4.31
AMEX : Health Care
Prev Close 6.27
Open 6.25
Day Low/High 6.00 / 6.35
52 Wk Low/High 5.18 / 11.26
Volume 2.18M
Avg Volume 2.67M
Exchange AMEX
Shares Outstanding 204.03M
Market Cap 1.28B
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

TherapeuticsMD Announces Second Quarter 2017 Financial Results

TherapeuticsMD Announces Second Quarter 2017 Financial Results

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced its financial results for the quarter ended June 30, 2017.

Interesting TXMD Put And Call Options For March 2018

Investors in TherapeuticsMD, Inc. saw new options become available today, for the March 2018 expiration.

TherapeuticsMD To Host Second Quarter Financial Results Conference Call And Webcast On August 3

TherapeuticsMD To Host Second Quarter Financial Results Conference Call And Webcast On August 3

TherapeuticsMD, Inc. (NYSE MKT:TXMD), an innovative women's healthcare company, today announced that it will host a conference call and live audio webcast to discuss its second quarter financial and business results on...

TherapeuticsMD Provides TX-004HR Regulatory Update

TherapeuticsMD Provides TX-004HR Regulatory Update

TherapeuticsMD, Inc. (NYSE MKT:TXMD), an innovative women's healthcare company, today announced a regulatory update regarding the New Drug Application (NDA) for TX-004HR, the company's investigational applicator-free...

First Week Of TXMD August 18th Options Trading

Investors in TherapeuticsMD, Inc. saw new options begin trading this week, for the August 18th expiration.

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of TherapeuticsMD, Inc. Shareholders And A Lead Plaintiff Deadline Of June 19, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of TherapeuticsMD, Inc.

The Klein Law Firm Announces A Class Action Filed On Behalf Of TherapeuticsMD, Inc. Shareholders And A Lead Plaintiff Deadline Of June 19, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of TherapeuticsMD, Inc.

TXMD INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving TherapeuticsMD, Inc. And A Lead Plaintiff Deadline Of June 19, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased TherapeuticsMD, Inc.

EQUITY ALERT: Levi & Korsinsky, LLP N Shareholders Of A Complaint To Recover Losses Suffered By Investors In TherapeuticsMD, Inc.

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of TherapeuticsMD, Inc.

TherapeuticsMD Announces Presentation At Jefferies 2017 Healthcare Conference On June 8

TherapeuticsMD, Inc. (NYSE MKT:TXMD), an innovative women's healthcare company, today announced that the company's CEO Robert Finizio will present at the Jefferies 2017 Healthcare Conference in New York on June 8.

July 21st Options Now Available For TherapeuticsMD (TXMD)

Investors in TherapeuticsMD, Inc. saw new options become available today, for the July 21st expiration.

TherapeuticsMD Enters Oversold Territory (TXMD)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Complaint To Recover Losses Suffered By Investors In TherapeuticsMD, Inc.

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of TherapeuticsMD, Inc.

TherapeuticsMD Announces Presentation At Bank Of America Merrill Lynch 2017 Healthcare Conference On May 16

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that the company's CEO Robert Finizio will present at the Bank of America Merrill Lynch 2017 Healthcare Conference in Las...

Analysts' Actions -- Costco, J.C. Penney, Cisco, TherapeuticsMD and More

Analysts' Actions -- Costco, J.C. Penney, Cisco, TherapeuticsMD and More

Here are Tuesday's top research calls, including downgrades for Cisco Systems and TherapeuticsMD, and new coverage of Costco and J.C. Penney.

Law Offices Of Howard G. Smith Reminds TherapeuticsMD, Inc. Investors Of Upcoming Lead Plaintiff Deadline And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith reminds investors of the upcoming June 19, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who purchased or otherwise acquired...

TXMD SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving TherapeuticsMD, Inc. And A Lead Plaintiff Deadline Of June 19, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased TherapeuticsMD, Inc.

Exiting Health Care Name

We'll close our TherapeuticsMD position with a likely major reset to expectations for the balance of 2017 and 2018.

TherapeuticsMD Rejected by FDA, Delay Could Be Fatal

TherapeuticsMD Rejected by FDA, Delay Could Be Fatal

The FDA wants 12-month endometrial safety data on TX-004HR. TherapeuticsMD conducted a single study that lasted just 12 weeks.

TherapeuticsMD Receives Complete Response Letter From FDA For TX-004HR New Drug Application

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that it received a Complete Response Letter (CRL) from the U.

Warily Awaiting TherapeuticsMD Call

The drug maker this morning is going to share the results of an FDA ruling, and we're concerned that the Street will shoot first and ask questions later.

TherapeuticsMD To Host TX-004HR Regulatory Update Conference Call And Webcast On May 8

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that, based upon the company's expectation that the U.

TherapeuticsMD Announces First Quarter 2017 Financial Results

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced its financial results for the quarter ended March 31, 2017.